CASEY PORTILLO: Open Payments
NPI 1063739381 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,699 in 77 payments from 19 companies in 2025. Trend: 2023 $1,236 · 2024 $1,462 · 2025 $1,699
Food & beverage: $1,656Education: $43
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $337 |
| Janssen Biotech, Inc. | 7 | $180 |
| Regeneron Healthcare Solutions, Inc. | 5 | $164 |
| Novartis Pharmaceuticals Corporation | 7 | $157 |
| Organon LLC | 3 | $147 |
| Lilly USA, LLC | 4 | $99 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $95 |
| Arcutis Biotherapeutics, Inc. | 4 | $78 |
| PFIZER INC. | 3 | $58 |
| Journey Medical Corporation | 2 | $55 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, VTAMA, RINVOQ, TALTZ, Zoryve, COSENTYX.
Industry payments across TX — which companies pay providers there.
